Your browser doesn't support javascript.
loading
Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma.
Liu, Kevin X; Milligan, Michael G; Schoenfeld, Jonathan D; Tishler, Roy B; Ng, Andrea K; Devlin, Phillip M; Fite, Elliott; Rabinowits, Guilherme; Hanna, Glenn J; Silk, Ann W; Yoon, Charles H; Thakuria, Manisha; Margalit, Danielle N.
Afiliação
  • Liu KX; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States.
  • Milligan MG; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States.
  • Schoenfeld JD; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States.
  • Tishler RB; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States.
  • Ng AK; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States.
  • Devlin PM; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States.
  • Fite E; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States.
  • Rabinowits G; Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, United States.
  • Hanna GJ; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Silk AW; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States.
  • Yoon CH; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States; Division of Surgical Oncology, Department of Surgery, Dana-Farber/Brigham and Women's Cancer Center, Boston, United States.
  • Thakuria M; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States; Department of Dermatology, Dana-Farber Cancer Institute, Boston, United States.
  • Margalit DN; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, United States; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, United States. Electronic address: danielle_margalit@dfci.harvard.edu.
Radiother Oncol ; 173: 32-40, 2022 08.
Article em En | MEDLINE | ID: mdl-35595174
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Célula de Merkel Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Célula de Merkel Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos